Abdul' Oseni, MD, FACC, FSCAI (@drabdul) 's Twitter Profile
Abdul' Oseni, MD, FACC, FSCAI

@drabdul

Interventional Cardiologist/Clinical Trialist @Norton_Health Trained @MeharryMedical @UIowaCVFellows @OUHealth #Coronary#Endovasc#Structural #USA #Auchi🇳🇬🇺🇸

ID: 66213762

calendar_today16-08-2009 22:59:53

403 Tweet

259 Followers

117 Following

Dr. Bill Lombardi (@drbilllombardi) 's Twitter Profile Photo

This week on Journey to Better: The incentives and culture that leads to the weaponization of peer review w/ Amir Kaki, MD drjourneytobetter.com/2084093/135144…

This week on Journey to Better:

The incentives and culture that leads to the weaponization of peer review w/ <a href="/DrAmirKaki/">Amir Kaki, MD</a> 

drjourneytobetter.com/2084093/135144…
Cardiac Trials (@cardiactrials) 's Twitter Profile Photo

PCI to improve symptoms in stable angina? This #AHA23 trial reaffirmed the role PCI plays in symptom relief, standing in stark contrast to its first generation counterpart (ORBITA, 2018). ORBITA-2 Trial, NEJM 2023 ♥️

PCI to improve symptoms in stable angina? This #AHA23 trial reaffirmed the role PCI plays in symptom relief, standing in stark contrast to its first generation counterpart (ORBITA, 2018). ORBITA-2 Trial, NEJM 2023 ♥️
CV Innovations (@cvinnovations) 's Twitter Profile Photo

What's better than attending CVI: The Operator's Enclave? Attending on a travel grant! Submit a Case or Abstract to earn a grant for travel, hotel and registration. Submission deadline is April 1st! cvinnovations.org/cvi2024/#casec… #cme #conference #cardiology #cardiologist

Abdul' Oseni, MD, FACC, FSCAI (@drabdul) 's Twitter Profile Photo

Using end-hole catheters for “LVgram” serves no purpose but has huge potential for causing harm. It only takes 1 to ruin lives and potentially careers. Get echo or use pigtail if truly needed. mandeep singh thanks for highlighting! Shubha Deep Roy, MD, FACC, FASE, FSCAI Seyi Bolorunduro MD MPH Srikanth Yandrapalli Emi Bob-Manuel, MD

NEJM (@nejm) 's Twitter Profile Photo

Presented today at #ACC24: In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t

Presented today at #ACC24: 

In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t
SCAI Now (@scai) 's Twitter Profile Photo

Addressing the #diversity gap in #valvular heart disease is crucial for better patient outcomes. Explore the latest findings in this TCTMD article. ➡️Read now: tctmd.com/news/valvular-…

Seyi Bolorunduro MD MPH (@seyi_dr) 's Twitter Profile Photo

The CVEF, in collaboration with the Nigerian Cardiac Society, invites you to the 11th Annual Cardiovascular Symposium. This free, 8-day virtual symposium offers a unique opportunity to delve into the latest concepts and advancements in cardiovascular medicine. Attendees benefit

Seyi Bolorunduro MD MPH (@seyi_dr) 's Twitter Profile Photo

from didactic lectures, case reviews, and group discussions led by expert faculty. You can register for one or more of the following Zoom sessions (all times are EST): Aug 3, 2024, 09:00 AM - Interventional Cardiology Aug 4, 2024, 09:00 AM - Pediatric Cardiology

Seyi Bolorunduro MD MPH (@seyi_dr) 's Twitter Profile Photo

Aug 10, 2024, 09:00 AM - Imaging Aug 11, 2024, 09:00 AM -EP Aug 17, 2024, 09:00 AM - CT Surgery Aug 18, 2024, 09:00 AM - Allied Health Aug 24, 2024, 09:00 AM - Heart Failure Aug 25, 2024, 09:00 AM - General Cardiology Register using the link below bit.ly/NCVS2024